In this study, T. siliquosa root extract was subjected to phytochemical profiling using GC-MS, followed by molecular docking, ADME prediction, cytotoxicity evaluation, cell cycle analysis, and cell migration assays to comprehensively assess its potential as a natural source of CDK-4 and CDK-6 inhibitors with possible therapeutic applications in cancer. This evidence concerns the gene CDK4 and cancer.